Goi G, Burlina A B, Moreschi C, Motta G, Bairati C, Lombardo A, Marini A, Tettamanti G
Dipartimento di Chimica e Biochimica Medica, Facoltà di Medicina e Chirurgia, Università degli Studi di Milano, Italy.
Acta Diabetol Lat. 1988 Oct-Dec;25(4):351-60. doi: 10.1007/BF02581134.
The serum levels of the two enzymes of lysosomal origin, beta-N-acetyl-D-glucosaminidase and beta-D-glucuronidase, and the isozyme pattern of the former, were determined in control infants and in infants of diabetic mothers (IDM) on the 1st and 5th day after birth. IDM were divided into three groups. Group 1: class A diabetic mothers treated dietetically; Groups 2 and 3: class A and classes B, C, D diabetic mothers, respectively, treated with insulin. All, but one, diabetic mothers were in excellent metabolic control. In the controls the serum levels of both enzymes were quite elevated on the 1st day after birth, reflecting the condition of the mothers at the end of pregnancy, and increased further on the 5th day, presumably as a result of the concurrent burst of antiinsulin hormones. In Group 1 IDM the serum levels of the two enzymes were higher than in controls, on the 1st day, probably reflecting the higher concentrations present in the mothers at the end of pregnancy than in controls, but equalling the condition of normal neonates on the 5th day. This indicates that IDM of this group had a normal post-natal response of the lysosomal apparatus to hormone stress. In Groups 2-3 IDM the enzyme levels on the 1st day could not be distinguished from those of controls, while on the 5th day a decrease was seen, suggesting reduced effect of the antiinsulin hormone burst on the lysosomal apparatus. The isozyme pattern of beta-N-acetyl-D-glucosaminidase in all IDM was similar to that of controls. The behavior of serum lysosomal enzymes of Groups 2-3 IDM is a further indication that the lysosomal apparatus is extremely sensitive to even small metabolic perturbations occurring in diabetic mothers during pregnancy.
在出生第1天和第5天,对对照组婴儿以及糖尿病母亲的婴儿(IDM)测定了两种溶酶体来源的酶,即β-N-乙酰-D-氨基葡萄糖苷酶和β-D-葡萄糖醛酸酶的血清水平,以及前者的同工酶谱。IDM被分为三组。第1组:通过饮食治疗的A类糖尿病母亲;第2组和第3组:分别接受胰岛素治疗的A类以及B、C、D类糖尿病母亲。除一名糖尿病母亲外,所有糖尿病母亲的代谢控制情况均良好。在对照组中,两种酶的血清水平在出生后第1天相当高,反映了母亲在妊娠末期的状况,并在第5天进一步升高,可能是由于同时出现的抗胰岛素激素激增所致。在第1组IDM中,这两种酶的血清水平在第1天高于对照组,这可能反映了母亲在妊娠末期体内的浓度高于对照组,但在第5天与正常新生儿的情况相当。这表明该组IDM的溶酶体装置对激素应激有正常的产后反应。在第2 - 3组IDM中,第1天的酶水平与对照组无差异,而在第5天则出现下降,提示抗胰岛素激素激增对溶酶体装置的影响减弱。所有IDM中β-N-乙酰-D-氨基葡萄糖苷酶的同工酶谱与对照组相似。第2 - 3组IDM血清溶酶体酶的表现进一步表明,溶酶体装置对糖尿病母亲在孕期发生的即使是微小的代谢紊乱也极其敏感。